15, June 2018
IG warns Biya: stay clear of Ambazonian refugee camps in Nigeria or face devastating consequences 0
The Interim Government of the Federal Republic of Ambazonia is challenging French Cameroun dictator President Paul Biya to ensure that no highly placed Cameroon government official visits Ambazonian refugee camps in Nigeria. Cameroon Concord News correspondent in the US reported that Acting President Dr. Ikome Sako has ordered self-defense forces in the Manyu County to be on the alert and to arrest or kill any Biya regime official visiting Southern Cameroons refugees in the Cross River State in Nigeria.
Confirming the President Sako decision, Ambazonian Communications Secretary, Hon. Chris Anu told Camcordnews that French Cameroun army soldiers deployed to Southern Cameroons created the horrific war that forced some 40, 000 Ambazonians to escape into hiding in neighboring Nigeria. Chris Anu further pointed out that the situation has changed as the Ambazonian Self-Defense Council Restoration Forces reasserted control, enabling the Interim Government’s presence to spread throughout Southern Cameroons.
Mr. Anu also warned that any visit of Southern Cameroons refugees in Nigeria by French Cameroun government officials was unacceptable. The Interim Government is expected to issue a strong statement on Monday to the international community condemning any move by La Republique du Cameroun towards the suffering Ambazonian population in Nigeria.
Cameroon Concord News gathered that the Ambazonian Interim Government has established a new calculus that has to take place and French Cameroun has to understand that the Federal Republic of Ambazonia will not tolerate any French Cameroun political or military entrenchment in Southern Cameroons. “The consequences of visiting the Ambazonian refugees in Nigeria will not merely be to the French Cameroun government officials and their entourage but to the Biya regime and its forces in Southern Cameroons as well. I think it’s something that Yaoundé should consider very seriously, added Chris Anu.
By Soter Tarh Agbaw-Ebai





















15, June 2018
Hong Kong scientists say new research points to universal antibody drug for HIV 0
A team of AIDS researchers in Hong Kong says its new research, tested on mice, indicates a functional cure for HIV, the virus that causes AIDS, eventually leading to a new antibody that could be used for both prevention and treatment.
The findings, published in the Journal of Clinical Investigation, come as China faces a growing epidemic among high-risk groups, such as sex workers and men who have sex with men.
The UN-supported AIDS Data Hub says about 850,000 people in China are infected with HIV, which disables the immune system and makes people far more vulnerable to infections and disease.
A team led by Professor Chen Zhiwei at Hong Kong University’s AIDS Institute says its discovery, tested on mice, shows the new antibody can help control the virus and eliminate infected cells.
The antibody would be able to treat all varieties of HIV – a first, Chen said – as there is no one vaccine to treat the many different types of HIV viruses.
“For our newly discovered bispecific antibody, it works for all of them, so that’s the major difference,” Chen told Reuters.
Chen and his team say they aim to bring the antibody into clinical trials within a timeframe of three to five years.
Chen said a “functional cure” meant the virus level would be so low as to be undetectable in the body, as long as patients kept taking injections of the antibody, perhaps on a quarterly basis, or less frequently.
Those infected with HIV can keep the virus under control with antiretroviral drugs that stop it from infecting new cells.
However, treatments must be taken daily and do not eliminate the infected cells from the body. So the virus can still exist, and symptoms return, if patients stop taking medication properly.
The new antibody would have a significantly longer half-life than current treatments, and could, for example, be administered on a quarterly basis, Chen said, making it easier than the daily treatment most HIV-infected patients face.
Promising results did not mean the treatment would be readily available soon, said Andrew Chidgey, chief executive of the charity group AIDS Concern in Hong Kong.
“Governments are being very slow to implement programmes here,” he added. “So just because a treatment becomes available, doesn’t mean that people will get it, or that it will have an impact.”
(Source: Reuters)